Earth Science Tech (ETST) Other Non-Current Liabilities (2024)
Earth Science Tech (ETST) posted Other Non-Current Liabilities of $42785.0 for Q4 2024, down 11.82% on a QoQ basis from $48522.0 in Q3 2024.
Earth Science Tech (ETST) Other Non-Current Liabilities (2024) Analysis & Trends
Earth Science Tech's Other Non-Current Liabilities history runs 1 years deep, the most recent figure standing at $42785.0 for Q4 2024.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $42785.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $42785.0 (changed N/A YoY) and the FY2024 annual result came in at $60559.0, changed N/A from the prior year.
- Other Non-Current Liabilities was $42785.0 for Q4 2024 at Earth Science Tech, down from $48522.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $60559.0 in Q1 2024 and bottomed at $42785.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 42,785.00 |
| Sep 30, 2024 | 48,522.00 |
| Jun 30, 2024 | 54,258.00 |
| Mar 31, 2024 | 60,559.00 |